Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia (Q73369927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

3

G L Vega

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

4

S M Grundy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

J M Mostaza

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

I Schulz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1298-1301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900109-4

10.1016/S0002-9149(97)00109-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164913%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference